Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis

Código QR

Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis

Yuqing Pan, Jun Yao, Baojie WangInstitute of Forensic Medicine, China Medical University, Shenyang, People’s Republic of ChinaAbstract: To date, the role of dopamine D1 receptor (DRD1) polymorphism in schizophrenia remains controversial. We carried out a meta-analysis to determine whethe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pan YQ, Yao J, Wang BJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a9e75353187b4a94b56892a32c422807
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis
por: Qi XL, et al.
Publicado: (2017)

Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis
por: He HR, et al.
Publicado: (2016)

A preliminary report of the dopamine receptor D4 and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder
por: Helmut Niederhofer, et al.
Publicado: (2008)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia
por: Xu F, et al.
Publicado: (2018)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda Y, et al.
Publicado: (2015)

Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
por: Athan Spiros, et al.
Publicado: (2010)

Association study of sepiapterin reductase gene promoter polymorphisms with schizophrenia in a Han Chinese population
por: Fu JW, et al.
Publicado: (2015)

Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms
por: Lozano R, et al.
Publicado: (2014)

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
por: Han JY, et al.
Publicado: (2017)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan R, et al.
Publicado: (2014)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari J, et al.
Publicado: (2013)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population
por: Otsuka I, et al.
Publicado: (2015)

Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment
por: Huang C, et al.
Publicado: (2015)

Differential effects of dopamine-directed treatments on cognition
por: Ashby FG, et al.
Publicado: (2015)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
por: Kishi T, et al.
Publicado: (2015)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai SL, et al.
Publicado: (2015)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
por: Ascher-Svanum H, et al.
Publicado: (2012)

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia
por: Chen L, et al.
Publicado: (2013)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Oya K, et al.
Publicado: (2015)

Exploration of sex differences in Rhes effects in dopamine mediated behaviors
por: Quintero GC, et al.
Publicado: (2011)

APRESS: apical regulatory super system, serotonin, and dopamine interaction
por: Hinz M, et al.
Publicado: (2011)

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease
por: Klimkowicz-Mrowiec A, et al.
Publicado: (2013)

The cost of schizophrenia in Japan
por: Sado M, et al.
Publicado: (2013)

Jumping to conclusions in schizophrenia
por: Evans SL, et al.
Publicado: (2015)

Analyzing a single nucleotide polymorphism in schizophrenia: a meta-analysis approach
por: Falola O, et al.
Publicado: (2017)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Schizophrenia and risk of dementia: a meta-analysis study
por: Cai LS, et al.
Publicado: (2018)

Pharmacotherapy for treatment-resistant schizophrenia
por: Meghan E Mcilwain, et al.
Publicado: (2011)

Profile of blonanserin for the treatment of schizophrenia
por: Tenjin T, et al.
Publicado: (2013)

Psychosurgery for schizophrenia: history and perspectives
por: Soares MS, et al.
Publicado: (2013)

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
por: Hisashi Higuchi,&nbsp;Hitoshi Takahashi, et al.
Publicado: (2009)

Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
por: Haybaeck J, et al.
Publicado: (2015)

Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb N, et al.
Publicado: (2012)

Emerging role of sertindole in the management of schizophrenia
por: Stephanie L Cincotta, et al.
Publicado: (2010)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012)

Role of sublingual asenapine in treatment of schizophrenia
por: Citrome L
Publicado: (2011)